HCK and acute myeloid leukemia: Hck expression is upregulated in chemotherapy-resistant AML leukemic stem cells [21], and inhibition of Hck with the ATP-competitive kinase inhibitor A-419259 prevented the engraftment of primary AML cells in genetically immunocompromised mice [22].